News

June 24-26
Holiday Inn Paris – Marne La Vallée 
2 boulevard du Levant, 93160 Noisy-le-grand
Paris, France

The 3rd Edition...

Dear COSTers,

the PUBLICATIONS page is now available on the public part of our website. All scientific publications resulting exclusively...

Cancer theranostics - first call

Dear COSTers,

on behalf of the organizer, Dr. Vladimir Sivakov, you are cordially invited to attend the 5thInternational...

COST Action CA17140 is the first, pan-European interdisciplinary network of representatives from academic institutions and small and medium enterprises including clinical research organizations (CROs) devoted to the development of nanosystems carrying anticancer drugs from their initial design, pre-clinical testing of efficacy, pharmacokinetics and toxicity to the preparation of detailed protocols needed for the first phase of their clinical studies.

By promoting scientific exchanges, technological implementation and innovative solutions, the Action will provide a timely instrument to rationalize and focus research efforts at the EU level in dealing with the grand challenge of nanomedicine translation in cancer, one of the major and societal-burdening human pathologies.

Useful downloads
European Cooperation in Science and Technology (COST) logo
EU flag logo

Funded by the Horizon 2020 Framework Programme
of the European Union